Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for postoperative sleep quality after gynecological laparoscopic surgery
ChiCTR2100053906Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in Postoperative sleep disturbance (PSD) (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Postoperative sleep. Started Jan 2022; status: completed.
02
Drugs
remimazolam
03
Conditions
Postoperative sleep disturbance (PSD)
Beyond the preview
Go deeper on ChiCTR2100053906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053906.